Show simple item record

dc.contributor.authorBall, S
dc.contributor.authorHyde, C
dc.contributor.authorHamilton, W
dc.contributor.authorBright, CJ
dc.contributor.authorGildea, C
dc.contributor.authorWong, KF
dc.contributor.authorPaley, L
dc.contributor.authorHill, HL
dc.contributor.authorMak, V
dc.contributor.authorMoffat, J
dc.contributor.authorElliss-Brookes, L
dc.date.accessioned2021-10-27T11:49:54Z
dc.date.issued2021-10-30
dc.description.abstractBackground. A two-phase ‘respiratory symptoms’ mass media campaign was conducted in 2016 and 2017 in England raising awareness of cough and worsening shortness-of-breath as symptoms warranting a GP visit. Method. A prospectively planned pre-post evaluation was done using routinely collected data on 15 metrics, including: GP attendance, GP referral, emergency presentations, cancers diagnosed (5 metrics), cancer stage, investigations (2 metrics), outpatient attendances, inpatient admissions, major lung resections and one year survival. The primary analysis compared 2015 with 2017. Trends in metrics over the whole period were also considered. The effects of the campaign on awareness of lung cancer symptoms were evaluated using bespoke surveys. Results. There were small favourable statistically significant and clinically important changes over two years in 11 of the 15 metrics measured, including a 2.11% (95% CI 1.02-3.20: p<0.001) improvement in the percentage of lung cancers diagnosed at an early stage. However, these changes were not accompanied by increases in GP attendances. Furthermore, the time trends showed a gradual change in the metrics rather than steep changes occurring during or after the campaigns. Conclusion. There were small positive changes in most metrics relating to lung cancer diagnosis after this campaign. However, the pattern over time challenges whether the improvements are wholly attributable to the campaign. Given the importance of education on cancer in its own right, raising awareness of symptoms should remain important. However further research is needed to maximise effect on health outcomes.en_GB
dc.identifier.citationPublished online 30 October 2021en_GB
dc.identifier.doi10.1038/s41416-021-01573-w
dc.identifier.urihttp://hdl.handle.net/10871/127595
dc.language.isoenen_GB
dc.publisherSpringer Nature / Cancer Research UKen_GB
dc.rights© The Author(s) 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
dc.titleAn evaluation of a national mass media campaign to raise public awareness of possible lung cancer symptoms in England in 2016 and 2017en_GB
dc.typeArticleen_GB
dc.date.available2021-10-27T11:49:54Z
dc.identifier.issn0007-0920
dc.descriptionThis is the final version. Available on open access from Springer Nature via the DOI in this recorden_GB
dc.identifier.eissn1532-1827
dc.identifier.journalBritish Journal of Canceren_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2021-09-30
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2021-09-30
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2021-10-27T10:39:43Z
refterms.versionFCDAM
refterms.dateFOA2021-11-12T15:34:40Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's licence is described as © The Author(s) 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.